EZH2 and pachyonychia congenita: According to the analysis results of the expression of EZH2 and prognosis of PC in TCGA, EZH2 was highly expressed in tumors, and the survival rate of patients with high expression of EZH2 was significantly lower than that of patients with low expression of EZH2 (Figures 1A,B).